Focal loss of laminar beams could cause lamina cribosa deformation

Article

Lamina cribosa (LC) deformation in glaucoma can be caused by focal loss of laminar beams

Lamina cribosa (LC) deformation in glaucoma can be caused by focal loss of laminar beams, claims a study in the Archives of Ophthalmology.

Dr Saman Kiumehr et al., Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, USA, included 92 eyes of 31 patients. Of the patients studied, 46 were healthy control subjects and 45 were glaucomatous.

Optical coherence tomography images of the optic nerve head were obtained from both groups of patients. Focal LC defects were defined as anterior laminar surface irregularities, sptial consistency, neuroretinal rim thinning/notching and visual field defects.

There were 98 focal LC defects found in 34 glaucomatous eyes and seven of the 11 glaucomatous eyes had a deeply excavated optic disc. Focal LC defects mostly occurred in the inferior or inferotemporal far periphery of the LC.

It was found that focal LC defects limited to the inferior half of the optic disc typically have greater sensitivity loss in the superior visual hemfield. Focal LC defects tend to occur in correlation with neuroretinal rim and visual field loss.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.